secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akebia Therapeutics, Inc. (AKBA)
CIK:        0001517022
Form:       8-K
Filed at:   2024-04-23T23:59:59+00:00
Accession:  0001517022-24-000035
Event type: debt
Sentiment:  neutral
Materiality: 0.30
Item codes: 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Akebia draws $8.0M Tranche B from Kreos loan facility; $10.0M Tranche C still available
--------------------------------------------------------------------------------

- Akebia drew $8.0M Tranche B loan on April 17, 2024, netting $7.5M after debt issuance costs and fees.
- Remaining borrowing capacity under Tranche C is $10.0M, available through December 31, 2024.
- Total facility remains $55M; initial $37M tranche was funded on January 29, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517022/000151702224000035/0001517022-24-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517022/000151702224000035/akba-20242304xkreosdrawdown.htm
  HTML page:      https://secwatch.observer/filing/0001517022-24-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer